Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint Inhibitors.

Detalles Bibliográficos
Publicado en:Targeted Oncology Vol. 19; no. 3; pp. 401 - 411
Autores principales: Uchimoto, Taizo, Tsuchida, Shuya, Komura, Kazumasa, Fukuokaya, Wataru, Adachi, Takahiro, Hirasawa, Yosuke, Hashimoto, Takeshi, Yoshizawa, Atsuhiko, Saruta, Masanobu, Hashimoto, Mamoru, Higashio, Takuya, Matsuda, Takuya, Nishimura, Kazuki, Tsujino, Takuya, Nakamura, Ko, Fukushima, Tatsuo, Nishio, Kyosuke, Yamamoto, Shutaro, Iwatani, Kosuke, Urabe, Fumihiko
Formato: Journal Article
Publicado: Springer Nature May2024
Acceso en línea:Ver este registro en EBSCOhost